Using magnetic heat therapy to improve treatment for brain tumors
Translational Application of Magnetic Hyperthermia Therapy with Adjuvant Therapies for Glioblastoma
This study is looking at a new way to treat glioblastoma, a tough type of brain cancer, by using tiny magnetic particles that heat up when exposed to a magnetic field, which could help make traditional treatments like radiation and chemotherapy work better while protecting healthy tissue.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10782010 on NIH RePORTER |
What this research studies
This research investigates the use of magnetic hyperthermia therapy (MHT) combined with traditional treatments for glioblastoma, a severe type of brain cancer. The approach involves delivering magnetic iron-oxide nanoparticles to the tumor site, which are then activated by a safe external magnetic field to generate localized heat. This heat aims to enhance the effectiveness of existing therapies like radiation and chemotherapy, potentially improving patient outcomes. The study addresses challenges related to the delivery and targeting of these nanoparticles to maximize treatment benefits while minimizing damage to surrounding healthy tissue.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma who are undergoing or have undergone standard treatments like surgery, radiation, and chemotherapy.
Not a fit: Patients with other types of brain tumors or those who are not eligible for standard glioblastoma treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and quality of life for patients with glioblastoma.
How similar studies have performed: Previous clinical trials have shown promising results for magnetic hyperthermia therapy in treating recurrent glioblastoma, indicating potential for success in this novel application.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Hadjipanayis, Constantinos George — University of Pittsburgh at Pittsburgh
- Study coordinator: Hadjipanayis, Constantinos George
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.